| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/24/2001 | CA2061101C Use of tba as a drug against stress in aquaculture |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2025326C Nmda antagonists |
| 04/19/2001 | WO2001027630A2 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027147A1 A novel molecule |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027129A1 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof |
| 04/19/2001 | WO2001027127A1 Tamoxifen and tamoxifen analogue glycosides and uses thereof |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027118A2 Bicyclic imidazo-5-yl-amine derivatives |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027111A2 Bicyclic imidazo-3-yl-amine derivatives |
| 04/19/2001 | WO2001027110A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027108A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 04/19/2001 | WO2001027104A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027091A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026736A2 Intraspinal compositions containing botulinum toxin for treating pain |
| 04/19/2001 | WO2001026705A2 A dual adhesive transdermal drug delivery system |
| 04/19/2001 | WO2001026669A1 A nascent gold based herbal composition |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026659A1 Medicament for treatment of neuropathies |
| 04/19/2001 | WO2001026657A1 Use of (r)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026621A2 Orally distintegrating composition comprising mirtazapine |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001002366A3 Substituted isoquinoline derivatives and their use as inticonvulsants |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000064423A3 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
| 04/19/2001 | WO2000061125A3 Osanetant in the treatment of mood disorders |
| 04/19/2001 | WO2000047236A8 Matrices for drug delivery and methods for making and using the same |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | US20010000326 Extracting flowering top of Hypercium perforatum (St.-Johns-wort) with alcohol or acetone solvent, filtering, concetrating then diluting the extract with water or water-alcohol solvent, then extracting with aliphatic ester |
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388681A1 Methods for treating pain |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2387535A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | CA2387493A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2385907A1 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2384544A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092026A2 Neurotransmission associated proteins |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091962A1 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 04/18/2001 | EP1091959A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament |
| 04/18/2001 | EP1091958A1 Salts of paroxetine |
| 04/18/2001 | EP1091956A1 Muscarinic antagonists |
| 04/18/2001 | EP1091950A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 04/18/2001 | EP1091949A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 04/18/2001 | EP1091946A1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091941A1 Novel benzimidazoles as corticotropin release factor antagonists |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091750A1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 04/18/2001 | EP1091741A1 Azepine derivatives having effects on serotonin related systems |
| 04/18/2001 | EP1091737A2 Calcium channel blockers |